Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [41] Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells
    Chang, Y
    Cheng, SD
    Tsai, CH
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (02): : 143 - 150
  • [42] Prognostic value of Epstein-Barr virus DNA load in nasopharyngeal carcinoma: a meta-analysis
    El Alami, Imane
    Gihbid, Amina
    Charoute, Hicham
    Khaali, Wafaa
    Brahim, Selma Mohamed
    Tawfiq, Nezha
    Cadi, Rachida
    Belghmi, Khalid
    El Mzibri, Mohammed
    Khyatti, Meriem
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [43] Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
    Nakanishi, Yosuke
    Wakisaka, Naohiro
    Kondo, Satoru
    Endo, Kazuhira
    Sugimoto, Hisashi
    Hatano, Miyako
    Ueno, Takayoshi
    Ishikawa, Kazuya
    Yoshizaki, Tomokazu
    CANCER AND METASTASIS REVIEWS, 2017, 36 (03) : 435 - 447
  • [44] Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma
    Akao, I
    Sato, Y
    Mukai, K
    Sugano, S
    Hoshikawa, T
    Suzuki, T
    Tsutsumi, K
    ACTA OTO-LARYNGOLOGICA, 1996, : 86 - 88
  • [45] Epstein-Barr virus: the future for screening, treatment and monitoring of nasopharyngeal carcinoma
    Davis, Joanne E.
    Smith, Mark C.
    Coman, William B.
    Moss, Denis J.
    FUTURE VIROLOGY, 2006, 1 (02) : 211 - 221
  • [46] Epstein-Barr virus infection and nasopharyngeal carcinoma: the other side of the coin
    Perri, Francesco
    Scarpati, Giuseppina Della Vittoria
    Giuliano, Mario
    D'Aniello, Carmine
    Gnoni, Antonio
    Cavaliere, Carla
    Licchetta, Antonella
    Pisconti, Salvatore
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1017 - 1025
  • [47] The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
    Gu, Ai-Di
    Zeng, Mu-Sheng
    Qian, Chao-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (10): : 13737 - 13747
  • [48] Correlation of nasopharyngeal carcinoma with rare earth elements and the Epstein-Barr virus
    Zhang, Xiangmin
    Zeng, Xiangfu
    Liu, Lianbin
    Lan, Xiaolin
    Huang, Jing
    Zeng, Hongxue
    Li, Rong
    Luo, Keqing
    Wu, Wei
    Zhou, Maohua
    Li, Shaojin
    ONCOLOGY LETTERS, 2018, 15 (04) : 4121 - 4128
  • [49] Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
    Kondo, Satoru
    Okabe, Atsushi
    Nakagawa, Takuya
    Matsusaka, Keisuke
    Fukuyo, Masaki
    Rahmutulla, Bahityar
    Dochi, Hirotomo
    Mizokami, Harue
    Kitagawa, Yuki
    Kurokawa, Tomoya
    Mima, Masato
    Endo, Kazuhira
    Sugimoto, Hisashi
    Wakisaka, Naohiro
    Misawa, Kiyoshi
    Yoshizaki, Tomokazu
    Kaneda, Atsushi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (02):
  • [50] Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma
    Masmoudi, Amine
    Toumi, Nabil
    Khanfir, Afef
    Kallel-Slimi, Lamia
    Daoud, Jamel
    Karray, Hela
    Frikha, Mounir
    CANCER TREATMENT REVIEWS, 2007, 33 (06) : 499 - 505